Trimedyne, Inc. reported earnings results for the third quarter and nine months ended June 30, 2013. For the quarter, the company reported net loss of $58,000, or $0 per share, compared to a net loss of $168,000, or $0.01 loss per share, for the same quarter ended June 30, 2012. Revenues for the third quarter ended June 30, 2013 were $1.68 million, compared to $1.71 million for the same quarter ended June 30, 2012.

Net loss for the nine months ended June 30, 2013 was $41,000, or $0 per share, compared to a net loss of $522,000, or $0.03 loss per share, for the same period ended June 30, 2012. Revenues for the nine months ended June 30, 2013 were $4.73 million, compared to $4.63 million for the same period ended June 30, 2012.